Newsfeeds - Spark Newswire

1 minute read

Trading Ideas

ABVC Biopharma Shares Volatile, Co. Mentioned Positively In Zacks Report

By Michael Horton

Today, 5:23 AM

-TradeXChange

ABVC

3 minute read

Penny Stocks

ABVC: Company Continues to Advance Lead Assets & Earlier Stage Candidates

By Zacks Small Cap Research

Today, 5:23 AM

By M. Marin NASDAQ:ABVC READ THE FULL ABVC RESEARCH REPORT

ABVC

2 minute read

News

ABVC BioPharma Offers 3 Updates On Vitargus

By Benzinga Newsdesk

Today, 5:23 AM

ABVC BioPharma, Inc. (NASDAQ:ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today provided an update regarding recent developments in

ABVC

3 minute read

Mid-Morning Market Update: Markets Edge Higher; Best Buy Earnings Top Estimates

By Lisa Levin

Today, 5:23 AM

Following the market opening Tuesday, the Dow traded up 0.11% to 35,374.12 while the NASDAQ rose 0.43% to 15,006.17. The S&P also rose, gaining 0.22% to 4,489.23.

ABVC

3 minute read

20 Stocks Moving in Tuesday’s Pre-Market Session

By Lisa Levin

Today, 5:23 AM

Gainers Baudax Bio, Inc. (NASDAQ: BXRX) rose 48.3% to $0.777 in pre-market trading after gaining over 3% on Monday. The company, earlier during the month, reported downbeat quarterly results.

ABVC

5 minute read

60 Biggest Movers From Yesterday

By Lisa Levin

Today, 5:23 AM

Gainers Trillium Therapeutics Inc. (NASDAQ: TRIL) shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pfizer for $18.50 per share, implying an equity value of $2.26 billion.

ABVC

2 minute read

The Week Ahead In Biotech: Cara FDA Decision, Ascendis Earnings, Aileron Data Presentation And More

By Shanthi Rexaline

Today, 5:23 AM

Biotech stocks swayed back and forth before ending the week lower. With earnings news dying down and an empty initial public offerings calendar, it was broader market cues, clinical readouts and regulatory actions that moved stocks during the week.

ABVC